Trial Profile
Antihypertensive Medications and the Risk of Sepsis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 Oct 2014 New trial record